Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Donisi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1980
[Evaluation of creatinine clearance in pediatric patients, excluding determination of creatininuria]L Astori, M Marino, C Donisi
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
[Modifications of the fluorescence method for detecting salmonella in feces]R Bisicchia, A Zunin, C Donisi
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|June 1, 1976
[Enzymatic determination of total serum cholesterol by 4-aminophenazone-phenol: manual and automatic method (author's transl)]R Savoldi, B D Prandini, C Donisi
ESMO Gastrointestinal Oncology|February 6, 2026
Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLYV Pusceddu, C Donisi, A Pretta, et al.
ESMO Open|September 2, 2025
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patientsA Pretta, V Nasca, F Marmorino, et al.
ESMO Open|June 25, 2026
Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 yearsA Pretta, G Rebecchi, G Maddalena, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1980
[Evaluation of creatinine clearance in pediatric patients, excluding determination of creatininuria]L Astori, M Marino, C Donisi
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
[Modifications of the fluorescence method for detecting salmonella in feces]R Bisicchia, A Zunin, C Donisi
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|June 1, 1976
[Enzymatic determination of total serum cholesterol by 4-aminophenazone-phenol: manual and automatic method (author's transl)]R Savoldi, B D Prandini, C Donisi
ESMO Gastrointestinal Oncology|February 6, 2026
Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLYV Pusceddu, C Donisi, A Pretta, et al.
ESMO Open|September 2, 2025
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patientsA Pretta, V Nasca, F Marmorino, et al.
ESMO Open|June 25, 2026
Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 yearsA Pretta, G Rebecchi, G Maddalena, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Pageof 1